{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:53:46Z","timestamp":1791104026747,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.10.022","type":"journal-article","created":{"date-parts":[[2007,11,10]],"date-time":"2007-11-10T12:15:37Z","timestamp":1194696937000},"page":"8518-8528","source":"Crossref","is-referenced-by-count":57,"title":["Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection"],"prefix":"10.1016","volume":"25","author":[{"given":"Rik L.","family":"de Swart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette G.","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs","family":"Kuiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Herfst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"van Amerongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Sprong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.10.022_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/89098","article-title":"A newly discovered human pneumovirus isolated from young children with respiratory tract disease","volume":"7","author":"Van den Hoogen","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.10.022_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/viro.2001.1355","article-title":"Analysis of the genomic sequence of a human metapneumovirus","volume":"295","author":"Van den Hoogen","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.10.022_bib3","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1086\/379200","article-title":"Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients","volume":"188","author":"Van den Hoogen","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.022_bib4","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1097\/01.inf.0000144668.81573.6d","article-title":"Human metapneumovirus as a major cause of human respiratory tract disease","volume":"23","author":"Crowe","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.10.022_bib5","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.inf.0000108190.09824.e8","article-title":"Clinical impact and diagnosis of human metapneumovirus infection","volume":"23","author":"Van den Hoogen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.10.022_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa025472","article-title":"Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children","volume":"350","author":"Williams","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.10.022_bib7","series-title":"Fields virology","first-page":"1601","article-title":"Respiratory syncytial virus and metapneumovirus","author":"Collins","year":"2007"},{"key":"10.1016\/j.vaccine.2007.10.022_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1086\/499274","article-title":"The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience","volume":"193","author":"Williams","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.022_bib9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nm1456","article-title":"A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines","volume":"12","author":"Moghaddam","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.10.022_bib11","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","article-title":"Adjuvants for human vaccines\u2014current status, problems and future prospects","volume":"13","author":"Gupta","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.022_bib12","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0264-410X(01)00301-2","article-title":"Immunopathogenesis of vaccine-enhanced RSV disease","volume":"20","author":"Openshaw","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.022_bib13","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.1128\/JVI.76.22.11561-11569.2002","article-title":"Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection","volume":"76","author":"De Swart","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.10.022_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jama.202.12.1075","article-title":"Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated virus vaccines","volume":"202","author":"Fulginiti","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.10.022_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/9473","article-title":"Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody","volume":"5","author":"Polack","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.10.022_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1086\/338009","article-title":"Altered synthesis of interleukin-12 and type 1 and type 2 cytokines in rhesus macaques during measles and atypical measles","volume":"185","author":"Polack","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.022_bib18","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm918","article-title":"A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles","volume":"9","author":"Polack","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.10.022_bib19","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1016\/j.vaccine.2007.04.075","article-title":"Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged","volume":"25","author":"Yim","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.022_bib20","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1128\/JVI.78.15.8264-8270.2004","article-title":"Recovery of human metapneumovirus genetic lineages A and B from cloned cDNA","volume":"78","author":"Herfst","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib21","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0002-9440(10)63750-9","article-title":"Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract","volume":"164","author":"Kuiken","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib22","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1128\/JVI.74.21.10074-10080.2000","article-title":"Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding","volume":"74","author":"O\u2019Doherty","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib23","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hygiene"},{"key":"10.1016\/j.vaccine.2007.10.022_bib24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1099\/vir.0.82663-0","article-title":"Experimental infection of macaques with human metapneumovirus induces transient protective immunity","volume":"88","author":"Van den Hoogen","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3201\/eid1004.030393","article-title":"Antigenic and genetic variability of human metapneumoviruses","volume":"10","author":"Van den Hoogen","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.022_bib26","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1128\/JVI.74.9.4236-4243.2000","article-title":"Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies","volume":"74","author":"Stittelaar","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/JCM.42.3.981-986.2004","article-title":"Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages","volume":"42","author":"Maertzdorf","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.0105-2896.2004.00215.x","article-title":"Interleukin-13 in asthma pathogenesis","volume":"202","author":"Wills-Karp","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2007.10.022_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000097357","article-title":"Role of cytokines in allergic airway inflammation","volume":"142","author":"Nakajima","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib30","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0264-410X(00)00213-9","article-title":"Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice","volume":"19","author":"Boelen","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.022_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-1759(02)00191-6","article-title":"A cautionary note on experimental artefacts induced by fetal calf serum in a viral model of pulmonary eosinophilia","volume":"268","author":"Ostler","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2007.10.022_bib32","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ni1420","article-title":"The innate signaling of dangers and the dangers of innate signaling","volume":"7","author":"Sansonetti","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ni0107-11","article-title":"Friendly and dangerous signals: is the tissue in control?","volume":"8","author":"Matzinger","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib34","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1099\/0022-1317-82-12-2881","article-title":"Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine","volume":"82","author":"Prince","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.10.022_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/14760584.5.5.695","article-title":"Live vaccines for human metapneumovirus designed by reverse genetics","volume":"5","author":"Buchholz","year":"2006","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.10.022_bib36","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.vaccine.2004.10.009","article-title":"A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys","volume":"23","author":"Tang","year":"2005","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T09:10:33Z","timestamp":1556961033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07011450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":36,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07011450"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}